2 01/05/2024 30/04/2025 2025-04-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-05-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 06557544 2024-05-01 2025-04-30 06557544 2025-04-30 06557544 2024-04-30 06557544 2023-05-01 2024-04-30 06557544 2024-04-30 06557544 2023-04-30 06557544 bus:RegisteredOffice 2024-05-01 2025-04-30 06557544 bus:Director1 2024-05-01 2025-04-30 06557544 bus:CompanySecretary1 2024-05-01 2025-04-30 06557544 core:WithinOneYear 2025-04-30 06557544 core:WithinOneYear 2024-04-30 06557544 bus:Micro-entities 2024-05-01 2025-04-30 06557544 bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 06557544 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 06557544 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 06557544 bus:FullAccounts 2024-05-01 2025-04-30
Company registration number: 06557544
Crossoak Pharma Ltd
Unaudited filleted financial statements
30 April 2025
Crossoak Pharma Ltd
Contents
Directors and other information
Director's report
Statement of financial position and notes to the financial statements
Crossoak Pharma Ltd
Directors and other information
Director Mr D Woodcock
Secretary Mrs M B Woodcock
Company number 06557544
Registered office 24 Shrublands Road
Berkhamsted
Hertfordshire
HP4 3HX
Crossoak Pharma Ltd
Director's report
Year ended 30 April 2025
The director presents his report and the unaudited financial statements of the company for the year ended 30 April 2025.
Director
The director who served the company during the year was as follows:
Mr D Woodcock
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 25 November 2025 and signed on behalf of the board by:
Mr D Woodcock
Director
Crossoak Pharma Ltd
Statement of financial position
30 April 2025
2025 2024
£ £ £ £
Fixed assets 1,585 2,201
_______ _______
Current assets 17,772 60,278
Prepayments and accrued income 3,935 4,037
_______ _______
21,707 64,315
Creditors: amounts falling due within one year ( 17,289) ( 20,822)
_______ _______
Net current assets 4,418 43,493
_______ _______
Total assets less current liabilities 6,003 45,694
Accruals and deferred income ( 60) ( 53)
_______ _______
Net assets 5,943 45,641
_______ _______
Capital and reserves 5,943 45,641
_______ _______
Crossoak Pharma Ltd
Year ended 30 April 2025
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 25 November 2025 , and are signed on behalf of the board by:
Mr D Woodcock
Director
Company registration number: 06557544
The company is a private company limited by shares, registered in England and Wales.